The seed stage venture capital fund announces key strategic partnerships with City of Hope and New York Cancer & Blood Specialists

NEW YORK, May 3, 2023 — Oncology Ventures is the trusted partner for early stage cancer startups. The seed stage venture capital fund invests in data and infrastructure startups that make cancer care more affordable, efficient and accessible.

Founder and Managing Partner, Ben Freeberg, has deep experience investing in healthcare startups — including Optum Ventures and Alpha Partners — and building a value-based cancer startup, Thyme Care. In addition to investing and building in the space, he has first-hand experience as a cancer patient himself. 

“When I was diagnosed with cancer five years ago, I was young, healthy and active,” shares Freeberg. “Even though I was familiar with our healthcare system, had incredible support from family and friends, and was treated by world class physicians at Memorial Sloan Kettering, dealing with cancer was not easy. Add in the rigorous chemotherapy treatments and 35+ medicines I took daily, and suddenly navigating cancer seemed impossible.”

“Considering oncology’s inherent complexity and reach, cancer startups deserve a dedicated cancer-focused venture fund to help them scale,” shares Freeberg. “We are proud to foster cancer innovation and are passionate about ensuring startups’ success by providing support around business model development, go-to-market strategy, hiring, strategic introductions and more.”

Oncology Ventures is thrilled to announce two strategic partnerships with:

1)  City of Hope: With an independent comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer treatment and care, research and development, academics and training, and innovation initiatives. City of Hope is ranked as the seventh best hospital for cancer in the nation and has received the highest rating possible by the National Cancer Institute.

2)  New York Cancer and Blood Specialists: NYCBS is the fastest growing cancer practice in the U.S. They recently opened a co-branded comprehensive Cancer Center with Memorial Sloan Kettering, which is the first of its kind. NYCBS offers an integrated and comprehensive approach that combines medical oncology, hematology, surgery, radiation, infusions, clinical trials, and supportive services to improve the quality of life throughout the cancer care continuum.

The Oncology Ventures team has already met with 250+ early stage cancer startups and is proud to announce its investments in:

• VivorCare: A fully-integrated cancer survivorship platform that is improving survivorship care for the 17M+ cancer survivors in the U.S.
• Gabbi: An early detection platform for breast cancer that aims to make late-stage breast cancer obsolete.
• Health Universe: An open-source community for Artificial Intelligence and Machine Learning that will impact precision medicine in oncology, clinical trial matching, cancer care navigation, and more.

Cancer spend in the U.S. is $210B, growing at 12% annually. These rising costs are unsustainable, as 42% of patients diagnosed with cancer lose their life savings within two years of diagnosis. Oncology Ventures is excited to invest in and support cancer startups that will improve care outcomes and reduce costs, bringing true value-based care to cancer.

If you and your cancer center, pharma company, health plan or health system are interested in partnering with Oncology Ventures to make cancer care more affordable, efficient and accessible, contact us for more information at [email protected]

Media Contact:
Katie Kosyan
[email protected] 
303-472-3705

SOURCE Oncology Ventures

Kapil Agrawal joins Outschool as CFO during a time of accelerated international expansion

SAN FRANCISCO, May 3, 2023 — Leading online learning platform Outschool is pleased to announce the hiring of Kapil Agrawal as the company’s new Chief Financial Officer. Agrawal brings with him a wealth of experience in finance and international expansion, having held leadership positions at several well-regarded start-ups including Poshmark and Uber.

Most recently, as Interim Chief Financial Officer at Poshmark, Agrawal helped significantly grow annual revenues and take the company public. Agrawal was also pivotal in improving Poshmark’s gross margins, unit economics, and profitability.

Prior to Poshmark, Agrawal served as Global Head of Pricing at Uber Technologies and before that he was the Head of Business Strategy at Capital One. Agrawal holds an M.B.A. from the University of Virginia Darden School of Business and Bachelor of Technology from Indian Institute of Technology (IIT) Bombay.

“We are thrilled to welcome Kapil to the Outschool team,” said Amir Nathoo, Outschool CEO. “His extensive experience in finance and business expansion will be invaluable to us as we continue to grow and scale our business in the years to come.”

As CFO, Agrawal will be responsible for overseeing all of Outschool’s financial operations and international expansion. Mr. Agrawal will work closely with the broader executive team to drive overall business strategy and growth as well as help the team’s ongoing international expansion.

“I have known Amir for a while now, and I truly admire his commitment to his mission of creating a platform where children can enjoy learning. My own children, aged 5 and 9, love Outschool as a platform,” said Kapil Agrawal, CFO of Outschool.

“My dad never completed his K-12 education, but he built a successful business. However, he always regretted not having access to quality education. To provide us with that access, he made a lot of sacrifices, which completely transformed our lives. I strongly believe that Outschool has the potential to change the lives of millions of children around the world by providing them with accessible and enjoyable quality education.”

Classes on Outschool range from one-time classes, to ongoing social groups, one-on-one tutoring, week-long camps, and ongoing courses. Classes are offered across all subjects, and for learners ranging from age 3 to 18. Founded in 2015, Outschool has been recognized not only for its popularity with parents and children alike but also its innovative approach to learning.

About Outschool

Outschool offers live online education experiences that connect teachers with learners in small-groups to explore everything from Minecraft, Pokemon and Cooking to Chemistry, Algebra and Literature. With over 100,000 online classes offered by teachers to learners around the globe, Outschool helps supplement what is often missing from a more traditional education. Outschool’s mission is to inspire kids to love learning by making education fun, social and self-directed. Classes on Outschool range from one-time enrichment lessons to semester-long core courses and weekly social clubs. Classes are offered across all subjects, and learners range from age 3 to 18. More information can be found at Outschool.com.

Media contact:
Kristen Marion
[email protected] 
623-308-2638

SOURCE Outschool

New Investment Fuels AP Automation Leader’s Growth, Expanding Global Footprint

OAKLAND, Calif., May 3, 2023 — OpenEnvoy, the Silicon Valley AI company that has built the industry-leading solution for accounts payable (AP) automation, today announced it secured $15 million in Series A financing led by RRE Ventures, including participation from Coelius Capital, Hack VC, Riot Ventures, and Uncorrelated Ventures.  

OpenEnvoy automates costly finance processes, preventing billions of dollars in overpayments. Through advanced AI, the OpenEnvoy platform rapidly digitizes invoices and performs reconciliation with 99 percent accuracy while eliminating costly billing errors and lengthy interdepartmental approval processes. OpenEnvoy processes all types of invoices, but is especially well known for its ability to manage high-volume, variable-cost invoices for complex accounts payables.

“We’re thrilled to continue pushing the boundaries in AI for automation of financial processes,” says Matthew Tillman, CEO of OpenEnvoy. “With this new round of funding, we’re well positioned to extend our industry leadership and growth. By automating AP and other financial processes, OpenEnvoy empowers finance teams to focus on more strategic activities that help our clients recognize significant hard dollar returns through improved cash flow and operational efficiencies.“

The market requires solutions that are highly accurate, processed in real-time, and deliver bottom-line value. OpenEnvoy’s best-in-class controls protect customers from vendor fraud, keep cash flow safe, and hold vendors accountable. The company’s industry-proven solutions also feature no-code integration to get clients up-and-running quickly and easily. Using AI to automate this tedious, repetitive work for AP teams frees up significant resources, increases effectiveness for faster time-to-value, and eliminates complex approval workflows while unleashing business creativity leading to new opportunities for growth and success.

“OpenEnvoy is poised to reshape an industry that has gone largely unchanged over the past 100 years,” says Jason Black, General Partner at RRE Ventures. “Invoice processing is still overwhelming, error-prone, and tedious even in the rare cases in which it has been fully-digitized. For most businesses, invoice processing is not a human scale problem any longer—that’s why most companies do spot checks, not full audits. OpenEnvoy’s unparalleled AI technology paired with its integrated document digitization and processing technology fundamentally transforms the AP function delivering immediate value and frequently saving customers millions in overpayments. As the lead investor in OpenEnvoy’s Series A round, RRE Ventures is extremely proud to support the growth of this category-defining company.”

 “OpenEnvoy digitizes highly complex invoices with full accuracy and the highest speed in the market,” says Will Coffield, General Partner at Riot Ventures. “They specialize in solving exceptionally complex challenges in extremely complicated industries including logistics, transportation and manufacturing. They’re modernizing old, insular industries – precisely why we’re doubling down in this round.”

“Our philosophy is that ideas are meaningless, validated ideas are priceless,” says Zach Coelius, Managing Partner at Coelius Capital. “We’re investing in OpenEnvoy because they’ve more than validated end-to-end automation being the key to success, especially with so many jobs evolving. Finance is about results, and capital markets want to see immediate, meaningful ROI.”        

“Finance teams demand greater efficiency, higher yield, and better cash flows by automatically identifying invoice discrepancies, automating the aging process, and uncovering valuable insights into vendor networks,” says Salil Deshpande, General Partner at Uncorrelated Ventures. “We’re investing in OpenEnvoy because companies are working with them to meet all of these needs. Organizations who aren’t, need to start doing so, yesterday.”

Learn how OpenEnvoy is transforming accounts payable by requesting your AP automation demo with an expert here.

About OpenEnvoy

OpenEnvoy empowers finance teams with advanced AI-driven visibility, automation, and cash flow solutions. Learn how the company prevents wasted spend by visiting www.openenvoy.com. Gartner names OpenEnvoy leading vendor for AP invoice automation. Read more at Future FinOps or follow @OpenEnvoy on Twitter and LinkedIn.

All trademarks and product names are the property of their respective companies.

Press Contact:
Gabriela Garner
Vice President of Marketing, OpenEnvoy
[email protected] 

SOURCE OpenEnvoy

NEW YORK , May 3, 2023 — Intrinsic, an omni-channel consumer health company, today announced a $15 million equity fundraise to focus exclusively on women’s health. The new capital, which brings the company’s total funding to $128 million raised to date, includes participation from new investors FCA Venture Partners and MAP Investco, along with existing investors Define Ventures, Link Ventures, Redesign Health, and others.

For Intrinsic, becoming a pure-play women’s health CPG company is a natural evolution. Since its inception, Intrinsic has built brands purposefully to address areas of unmet needs in consumer health and has found an enormous opportunity in women’s health. Women have been under-served by the healthcare system for centuries, leaving a vast unmet need for women across life stages and conditions. In addition to managing their own health, women are the primary caregiver for children and aging parents in 80% of cases. To meet their own healthcare needs and care for their families, women often turn to consumer health products. However, none of the large consumer health companies focus exclusively on women. This creates white space and a unique opportunity to build a different kind of company.

“Our team acquires, builds, and grows brands that serve women, not only because there is a unique opportunity to build a company dedicated to women’s health, but because it is the right thing to do,” says Yadin Shemmer, Co-founder and Chief Executive Officer, Intrinsic. “There is a large, fragmented universe of independent brands that serve women in specific areas of need but no scaled platform that provides branded solutions across the spectrum of women’s health. By putting women first, we deliver on our promise of making women’s lives easier, healthier, and more fulfilling. Moreover, by focusing exclusively on women’s health, we gain marketing and omni-channel distribution advantages that no single brand can achieve. This also means innovative and important products can now be accessible wherever women need them.”

Intrinsic’s definition of women’s health doesn’t stop at just women-specific conditions. It looks at women as the chief healthcare consumer and caregiver, with a more holistic view of her true needs and burdens. This encompasses conditions that affect women disproportionately or differently, as well as health priorities when caring for loved ones.

With the help of its team of investors and medical advisory board  – consisting of a female majority membership with seasoned experience across the obstetrics, gynecology, and fertility fields, including Dr. Laurie Green (Obstetrics/Gynecology, Harvard), Dr. Dena Bravata (Internal Medicine, Stanford) and Dr. Nimisha Kalia (Internal Medicine, Johns Hopkins) – the Company is able to effectively acquire brands and launch new products to more efficiently remove the barriers that prevent women from achieving optimal health and well-being. 

Once the company acquires a women’s health brand,  it expands its reach and impact through a mix of channel expansion, new product development, and connected marketing. This enables Intrinsic’s brands to engage women across the consumer and patient journey wherever they seek answers, seek care, or shop. In addition, the firm’s proprietary analytics provide automation and unique insights that enable faster action and better decisions across all company functions, including acquisitions, marketing, and supply chain.

Quickly becoming the new home for women’s health brands across the US, the company’s current portfolio focuses on mothers in the prenatal and postpartum phases through a range of offerings, including devices, consumables, and topical treatments. These unique brands reach millions of women around the globe, continually win numerous accolades, including the National Parenting Product Awards (NAPPA) and Mom’s Choice Awards, maintain Amazon’s Choice and Best Seller status on the platform with tens of thousands of five-star reviews, and receive continued praise from prominent media like Forbes, Yahoo, Parents, The Bump, Huffington Post, Motherly, New York Magazine and more. Intrinsic’s current portfolio has global reach, with sales in North America, Europe, Asia, and the Middle East. The company’s brands have averaged 60% growth post-acquisition and achieved omni-channel distribution in both retail and healthcare.

“Intrinsic is not only rewriting the rules of women’s consumer health products, but it is also building a platform for global women’s health,” says Lynne Chou O’Keefe, Partner, Define Ventures, and a member of Intrinsic’s board of directors. “Women are the power buyers in healthcare and make 80% of healthcare decisions in the home. Intrinsic’s strategy recognizes this reality and is uniquely poised to support women across their journey.”

For more information, please visit intrinsic.us.

Intrinsic builds brands that make a difference in the lives of women and those they love. The company focuses on women’s health brands that solve unmet needs, expanding their global reach by opening up new distribution channels across eCommerce, retail, and healthcare. The company is based in New York, NY, and its investors include Define Ventures, FCA Venture Partners, Redesign Health, Link Ventures, MAP Investco, and others. For more information, please visit intrinsic.us.

Media Contact:
Liz Fleming
[email protected]

SOURCE Intrinsic

The Music Financing Platform Is Bringing Investment Opportunities to the Fastest Growing Segment of the Music Industry and Giving Independent Artists The Ability To Sell Their Masters

NEW YORK, May 3, 2023 — Duetti, a new music financing startup founded by Lior Tibon, former COO of TIDAL, and Christopher Nolte, former Business Development executive at Apple Music, today announces its public launch. Duetti’s unique model unlocks immediate cash flow for a wide range of artists, allowing them to sell master catalogs, individual tracks, or even parts thereof, an opportunity previously only accessible to a small group of A-list artists. This innovative model opens new investment opportunities for a previously untapped asset class.

Duetti’s highly scalable data-centered approach generates exceptional long-term financial returns for the company and its partner artists by deploying a range of innovative management and optimization tactics. Backed by $32M in funding from Viola Ventures and Viola Credit, Roc Nation, Untitled and Presight Capital, Duetti is uniquely positioned to disrupt the music financing market.

Since starting its initial operations, Duetti has quickly become an essential business tool for over 60 independent artists including CVBZ, Sylvan LaCue, and Croosh, partnering on deals across over 100 tracks. To date, Duetti has facilitated music rights acquisitions that saw artists receive up to $400,000 per deal. With the funding, Duetti aims to scale the business to match the growing demand by expanding the team, partnering with new artists, and implementing new financial optimization opportunities for acquired tracks and catalogs.

“In recent years, the trend of legacy A-list musicians selling their entire catalogs has left independent artists out of the equation. Now, artists at all stages of their careers can easily capture the potential of their tracks and catalogs to help them reach the next step of their journey,” says Lior Tibon, CEO of Duetti. “We are arming artists with the information they need to choose when, and how, to leverage their assets from a position of strength”

Duetti is tapping into the most vibrant and fastest growing segment of the music industry, unlocking catalog sales opportunities for over 70,000 independent artists. These artists can access a new level of financial and long-term career sustainability, allowing them to focus on their creative pursuits. Artists can quickly tap into a meaningful cash payout that they have control over – whether they’re looking to buy a house, fund a tour, or record their next project.

“Duetti’s cutting edge technology enables efficient analysis of an artist’s potential for successfully monetizing a catalog or track – we are incredibly excited by the potential of their business model and the new, independent investment class it unlocks,” says Avi Zeevi, Co-Founder of Viola Ventures and a fintech investor. “Independent artist revenue growth is outpacing the entire industry and their highly scalable model returns revenue uncorrelated to broader market and economic conditions. A win-win for investors and musicians.”

On average, Duetti’s deals take roughly 30 days to complete, and artists with tracks that have been on streaming platforms for at least 2 years, and have garnered at least 500,000 streams in the last 12 months can learn more about master sale opportunities on Duetti.co.

About Duetti
Duetti was founded by Lior Tibon, former COO of TIDAL, and Christopher Nolte, former Business Development executive at Apple Music, with the mission of getting a wide range of artists quick and easy access to catalog sales and unlocking new investment opportunities. Leveraging their experience in streaming and support from music and tech’s most innovative investors including Viola Ventures and Roc Nation, Duetti’s music financing platform has helped over 60 artists receive up to $400,000 for their catalog and single-track masters. The unique model provides data-driven prices for established tracks, allowing artists to sell individual tracks or even parts thereof, while Duetti then markets those tracks going forward using unique ROI-focused techniques.

SOURCE Duetti

WASHINGTON, May 3, 2023 — Range, the all-in-one AI WealthTech platform, announced it had raised $12m in funding led by Gradient Ventures, Google’s AI-focused venture fund. The round also included Expa (founded by Garrett Camp, former Chairman and Co-founder of Uber), Red Sea Ventures, 8-bit Capital, and individuals Randy Reddig (co-founder, Square), Adrian Aoun (CEO & founder at Forward Health), Severin Hacker (co-founder & CTO of Duolingo), and Dan Lewis (co-founder & CEO of Convoy).

“We started this company to help families better manage their wealth,” said Fahad Hassan, co-founder and CEO of Range. “With our new investors and their experience in AI, we believe this partnership and financing will allow us to assist families during unprecedented times of economic change and uncertainty. Our products will allow everyone to access the advice and tools typically only available to the wealthy.”

The funding will be used primarily to grow the product and engineering teams to accelerate offerings to Range’s customers. Range plans to integrate their wealth management tools with various AI technologies to automate aspects of wealth and tax planning.

“Understanding your current wealth and where your family can develop new opportunities for wealth creation is on the minds of everyone. The team at Range is determined to leverage new technologies, specifically AI and large-language models, to give families more control and visibility into their financial future_,” said Darian Shirazi, General Partner at Gradient Ventures, who also joins Range’s board of directors. “We’re thrilled to partner with Fahad, David, and the entire Range team as they pursue their noble vision to improve the financial lives of families globally. “

Range was founded in 2021 by Fahad Hassan and David Cusatis. An all-in-one wealth management tool to make financial planning accessible to everyone, Range has in-house financial advisers to optimize investment services, tax planning, estate planning, retirement planning and insurance needs.

ABOUT RANGE
Range puts wealth management into the hands of everyone with a platform aimed at simplifying and democratizing access. The all-in-one tools are powered by proprietary AI technology and aided by a team of world class licensed financial advisors. With no minimums required, personalized guidance, financial tools, machine-learning insights, and 24/7 support, Range is revolutionizing the wealth management industry. For more information, visit www.range.com.

ABOUT GRADIENT VENTURES
Gradient Ventures, Google’s AI-focused venture fund, helps founders build transformational companies. The fund focuses on helping founders navigate the challenges in developing new technology products, using the latest best practices in recruiting, marketing, design, and engineering so that great ideas can come to life. Gradient was founded in 2017 and is based in Palo Alto, California. For more information, visit www.gradient.com.

SOURCE Range

BETHESDA, Md., May 2, 2023 — SAR, a data analytics company specialized in U.S. public company risk management solutions, is pleased to announce the closing of a capital investment in the Company led by institutional investor, Anthem Management (“Anthem”). Anthem’s investment provides SAR with long-term growth capital to execute on the organization’s mission and innovation roadmap. SAR also welcomes Daven R. Shastri, Managing Partner of Anthem, to the newly created Board of Directors. Shastri brings proven institutional investing experience to the board with tenures at Goldman Sachs and Diameter Capital Partners prior to founding Anthem. His insights into capital allocation and strategy will provide invaluable counsel to the Company. 

Shastri remarked, “We’re excited to have completed our investment in SAR. Our focus on secular growth and strong leadership makes SAR a compelling partner at this stage of the Company’s lifecycle. We look forward to working with Nessim and the entire SAR team to continue driving innovation and responsible disruption in the space. Our investment in the Company represents a long-term commitment to both the business and industry. We’re thrilled to be able to provide support to SAR as it grows into a core service provider for insurance clients.” 

Leading global insurance companies rely on the SAR Platform with integrated fit-for-purpose data analytics tools to protect publicly traded companies and their directors and officers. This capital infusion will strongly advance SAR’s implementation of the U.S. Federal Court-approved event study methodology to institutionalize its application to better-serve global insurers with robust public company underwriting analytics, diligent handling of complex securities claims, and empirically backed actuarial support.  

“Focus and diligence have served SAR well since our inception. I am confident in selecting Anthem to be our lead long-term capital growth partner. With Daven on our Board, SAR will lead the public company D&O insurance space through responsible technological innovation by advancing the development of new risk management solutions for publicly traded companies listed in the U.S.,” said Nessim Mezrahi, CEO of SAR.

About SAR 

SAR is a pioneer in public company risk management data analytics solutions. The Company was founded in 2018 and relies on specialized data science that implements U.S. Federal Court-approved methodologies to identify and track adverse corporate events that impact stock price performance of U.S. and non-U.S. issuers that trade on the NYSE and NASDAQ. Through a cloud-native platform, SAR dispenses comprehensive data-driven insights for leading global insurance companies and their distribution partners. Highly specialized expertise, decades of independent empirical research, and tried and true technologies, have established SAR as an innovation leader in public company data analytics solutions anchored by human accountability.

Media Contact:
[email protected]

SOURCE SAR

Regulatory Submission Management pioneer invests in new way for regulatory affairs and risk management teams to maximize speed and success of their submissions

LOS ANGELES, May 2, 2023 — Essenvia, the pioneer in regulatory submission management for the MedTech industry, today announced it closed $4M in Pre Series A financing led by Benhamou Global Ventures and Wavemaker360 with participation from existing investors First Rays, Rebright partners, as well as Pasadena Angels. The company announced the appointment of Wavemaker360 partner Kwame Ulmer and BGV Partner Yashwanth Hemaraj to Essenvia’s board of directors.

“Investing in Essenvia was an easy decision,” said Kwame Ulmer, Partner at Wavemaker360. “As someone who’s spent over 20 years in the industry as well as 12 years at the FDA, I’ve seen all of the pitfalls medical device manufacturers hit when navigating the complexity and pace of regulatory changes to bring their products to market. This gap has been amplified by a new wave of digital health regulations. Essenvia is the only solution that has actually dealt with every single one of them through its highly effective, easy-to-use platform. It’s no wonder their customers have a 100% acceptance rate – nobody else in the industry can claim that.”

According to the FDA, 71% of regulatory submissions are rejected, costing manufacturers an estimated $1.8M in lost revenue for every 6-8 weeks in delay – the statistic holds true even for MedTech companies with less than 50 employees. This burden puts regulatory affairs teams squarely in a position to either accelerate or stifle the market potential of new devices.

“Enterprise 4.0 businesses are reshaping the fundamentals of automation-led value creation,” explains BGV partner Yashwanth Hemaraj.  “Essenvia is leveraging disruptive AI technologies with novel data sets to offer a verticalized solution that supercharges the work of MedTech regulatory professionals. By providing frictionless deployments that are embedded directly into existing workflows, their solution can generate immediate gains for end customers.”

Essenvia’s fundamentally different approach to regulatory submission management is being rapidly adopted by MedTech organizations worldwide. Unlike conventional Regulatory Information Management (RIM) tools, documents, or spreadsheets, Essenvia has zero technical implementation time and works seamlessly with a regulatory team’s existing process. The platform empowers teams to natively collaborate on 510(k), MDR and IVDR submissions directly inside of a submission, error check them, dynamically publish and re-publish them with one click, and instantly submit using the latest agency-specific technical requirements. This saves regulatory professionals dozens of tedious hours wasted on researching information, eliminates submission errors, and radically shortens submission time to market. Essenvia has a 100% acceptance rate across hundreds of different types of complex global submissions including 510(k)s, MDR and IVDR tech files.

“Regulatory affairs professionals are on an unsustainable path of doing more with less, faster, with a significant impact on a MedTech company’s commercial goals,” said Soumya Mahapatra, Essenvia’s Co-founder and CEO. “The only way to keep up is to change the paradigm with a platform that is built for the modern way they work and interact with their cross-functional teams and regulatory agencies. We’ve built just that – and we’re just getting started.”

Essenvia is pioneering the regulatory submission management process with:

• Market-leading submission editing and collaboration
• One-click preview and publishing
• Real-time error analysis
• Dynamic reference and appendix building
• Secure file vault with PDF auto-conversion
• Native eStar submission
• No technical implementation – get started on day 1

Read more about this announcement on our blog.

To learn more, visit Essenvia.com.

About Essenvia

Essenvia is the pioneer in regulatory submission management for the MedTech industry. Unlike conventional Regulatory Information Management (RIM) tools, documents, or spreadsheets, Essenvia has zero technical implementation time and works seamlessly with a regulatory team’s existing process. The platform empowers teams to natively collaborate on 510(k), MDR and IVDR submissions directly inside of a submission, error check them, dynamically publish and re-publish them with one click, and instantly submit using the latest agency-specific technical requirements. This saves regulatory professionals dozens of painfully tedious hours wasted on researching information, eliminates submission errors, and radically shortens submission time to market. Essenvia has a 100% acceptance rate across hundreds of different types of complex global submissions including 510(k)s, MDR and IVDR tech files. Essenvia is backed by leading venture capital firms including Wavemaker360 and Benhamou Global Ventures. Learn more at www.essenvia.com.

About Wavemaker 360

Wavemaker Three-Sixty Health (Wavemaker 360) is the nation’s leading seed-stage healthcare pure-play venture fund in the U.S., focused on disruptors in the areas of health-tech, digital health, medical device, telehealth, artificial intelligence, pharma-tech, science and marketplaces. Wavemaker 360 stands apart as one of the few venture funds in the U.S. that discovers, vets and invests solely in healthcare startups at the seed funding stage. The fund connects its portfolio companies to a network of 300 Limited Partners (LPs), comprised of healthcare entities and executives in virtually every area of healthcare. Headquartered in Pasadena, CA, Wavemaker 360 is led by a cross-functional, bi-coastal team of eight visionary partners, with additional guidance from a distinguished Council of Strategic Advisors.

About BGV

BGV is a venture capital firm with deep Silicon Valley roots and an exclusive focus on global Enterprise 4.0 technology innovation.  The partnership sources companies from innovation hubs around the world and deploys financial and human capital from seed stage to IPO. With offices in Palo Alto, Tel Aviv, Paris, and Mumbai, BGV has championed a cross-border venture investing model with a portfolio representing businesses in the US, Israel, Europe, and India.

Contacts
Essenvia PR Team
[email protected]

SOURCE Essenvia

DALLAS, May 2, 2023 — MB2 Dental (“MB2” or the “Company”), a leading dental partnership organization, today announced the closing of an amendment to the Company’s existing debt facility, establishing a new delayed-draw term loan (“DDTL”) in the aggregate principal amount of $150 million.

MB2 also completed a successful fundraise for its ninth internal investment “sidecar” vehicle, totaling a record $20 million. Since the inception of “sidecar” investments, MB2 doctor partners have invested over $75 million to help fuel the Company’s growth. This equity offering allows doctor partners to invest alongside the Company – a long-standing opportunity made exclusively to this group as part of MB2’s unique doctor-centric model.

Dr. Chris Steven Villanueva, Founder and Chief Executive Officer said, “We truly appreciate the support and collaboration from Charlesbank and our lenders, securing a path for ongoing growth in this challenging environment. We’re also excited to have our doctor partners continue participating in MB2’s record investment returns.”

The funding will be deployed towards upcoming acquisitions, expanding MB2’s current network of over 550 practices across 38 states.

About MB2 Dental

Dallas, Texas-based MB2 Dental is a first-of-its-kind Dental Partnership Organization (DPO) founded and led by dentist and entrepreneur CEO Dr. Chris Steven Villanueva, with a mission to empower dentists to preserve their profession. Since its founding in 2007, MB2 has partnered with hundreds of dentists to help them stay in the driver’s seat as they maximize their talents, connect as part of a community and build exceptional wealth. MB2 currently partners with dentists and specialists in more than 35 states. For more information, visit https://mb2dental.com.

Press Contact:
Lindsey Byrnes
9728693789
https://mb2dental.com

SOURCE MB2 Dental